Stephen Weiss Selected for Inclusion on the 2025 Lawdragon Legends List

Seeger Weiss LLP is proud to announce that founding partner Stephen Weiss has been selected for inclusion on the 2025 Lawdragon Legends list.

February 7, 2025

Lawdragon SW Stephen Weiss Legends List

Seeger Weiss LLP is proud to announce that founding partner Stephen Weiss has been selected for inclusion on the 2025 Lawdragon Legends list. Lawdragon Legends represents an elite group of attorneys who have been recognized in The Lawdragon 500 Leading Lawyers in America at least ten times, showcasing a career of sustained excellence, leadership, and impact.

As Chair of Seeger Weiss’s qui tam/whistleblower practice, Weiss has led high-stakes litigation in healthcare and tax fraud, securing groundbreaking recoveries against major corporations, including CareCore National, Warner Chilcott, and Life Spine, Inc. In March 2023, he helped achieve a $10 million settlement with Stimwave for False Claims Act violations, exposing fraudulent medical device sales that led to Medicare overbilling.

Weiss’s practice spans a diverse array of high-profile litigations, including agriculture, securities, employment, environmental, and clergy sexual abuse cases. His work has led to some of the largest settlements in U.S. history, including a $1.51 billion nationwide class action settlement in the Syngenta AG MIR162 Corn Litigation.

In announcing the honorees, Lawdragon highlighted the exceptional caliber of attorneys selected:

“Nowhere will you find a collection of lawyers as vibrant, diverse, insightful, tough, and brilliant as those assembled here. This is our toughest group in which to win admittance – requiring not just excellence, but the drive and determination to be the best.”

Lawdragon’s selection methodology can be found here.

No aspect of this or any advertisement has been approved by the Supreme Court of New Jersey.

Prior results do not guarantee or predict a similar outcome in any future matter.

Related News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More